Gene transfer and expression in oligodendrocytes under the control of myelin basic protein transcriptional control region mediated by adeno-associated virus

Gene Therapy

Volumn 5, Issue 1, 1998, Pages 50-58

  Chen, H ^a   McCarty, D M ^a   Bruce, A T ^a   Suzuki, K ^a,a  

^a UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

Author keywords

AAV; Central nervous system; Gene therapy; Green fluorescent protein (GFP); MBP promoter

Indexed keywords

GREEN FLUORESCENT PROTEIN; MYELIN BASIC PROTEIN;

ADENO ASSOCIATED VIRUS; ANIMAL CELL; ARTICLE; CONTROLLED STUDY; CYTOMEGALOVIRUS; EXPRESSION VECTOR; GENE EXPRESSION; GENE TARGETING; GENE TRANSFER; GENETIC TRANSDUCTION; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; NERVE CELL CULTURE; NONHUMAN; OLIGODENDROGLIA; PRIORITY JOURNAL; PROMOTER REGION; RAT; RECOMBINANT GENE; REPORTER GENE; TRANSCRIPTION REGULATION; VIRUS RECOMBINANT; WHITE MATTER;

ADENO-ASSOCIATED VIRUS; ANIMALIA; CUCUMBER MOSAIC VIRUS; CYTOMEGALOVIRUS;

EID: 0031983640     PISSN: 09697128     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.gt.3300547     Document Type: Article

References (28)

1. Neuwelt EA et al. Gene replacement therapy in the central nervous system: viral vector-mediated therapy of global neurodegenerative disease. Behav Brain Sci 1995; 18: 1-9
2. Friedmann T. Gene therapy for neurological disorders. Trends Genet 1994; 10: 210-214
3. Wolff JA. Postnatal gene transfer into the central nervous system. Curr Opin Neurobiol 1993; 3: 743-748.
4. Suhr ST, Gage FH. Gene therapy for neurological disease. Arch Neural 1993; 50: 1252-1268.
5. Du B, Wu P, Boldt-Houle DM, Terwilliger EF. Efficient transduction of human neurons with an adeno-associated virus vector. Gene Therapy 1996; 3: 254-261.
6. Kaplitt MG et al. Long-term gene expression and phenotypic correction using adeno-associated virus vectors in the mammalian brain. Nat Genet 1994; 8: 148-154.
7. Xiao X, deVlaminck W, Monahan J. Adeno-associated virus (AAV) vectors for gene transfer. Adv Drug Delivery Rev 1993; 12: 201-215.
8. Samulski RJ et al. Targeted integration of adeno-associated virus (AAV) into human chromosome 19. EMBO J 1991; 10: 3941-3950
9. Pfeiffer SE, Warrington AE, Bansal R. The oligodendrocyte and its many cellular processes. Trends Cell Biol 1993; 3: 191-197.
10. McCown TJ et al. Differential and persistent expression patterns of CNS gene transfer by an adeno-associated virus (AAV) vector Brain Res 1996; 712: 99-107.
11. Chalfie M et al. Green fluorescent protein as a marker for gene expression. Science 1994; 263: 802-805.
12. Zolotukhm S et al. A 'humanized' green fluorescent protein cDNA adapted for high-level expression in mammalian cells. J Viral 1996; 70: 4646-4654.
13. Gow A, Friedrich VL, Lazzarmi RA. Myelin basic protein gene contains separate enhancers for oligodendrocyte and Schwann cell expression. J Cell Biol 1992; 119: 605-616.
14. McMaster GK, Beard P, Engers HD, Hirt B. Characterization of an immunosuppressive parvovirus related to the minute virus of mice. J Virol 1981; 38: 317-326.
15. Hayes C et al. Expression of the neu oncogene under the transcriptional control of the myelin basic protein gene in transgenic mice: generation of transformed glial cells. J Neurosci Res 1992; 31: 175-187.
16. Raff MC, Miller RH. A gha progenitor cell that develops in vitro into an astrocyte or an oligodendrocyte depending on culture medium. Nature 1983; 303: 390-396.
17. Doll RF et al. Comparison of promoter strengths on gene delivery into mammalian brain cells using AAV vectors. Gene Therapy 1996; 3: 437-447.
18. Peel AL et al. Efficient transduction of green fluorescent protein in spinal cord neurons using adeno-associated virus vectors containing cell type-specific promoters. Gene Therapy 1997; 4: 16-24.
19. Szuchet S. The morphology and ultrastructure of oligodendrocytes and their functional implications. In. Kettenmann H, Ransom BU (eds). Neuroglia. Oxford University: New York, 1995, pp 23-44.
20. Butt AM et al. Three-dimensional morphology of astrocytes and oligodendrocytes in the intact mouse optic nerve. J Neurocytol 1994; 23: 469-485.
21. Butt AM, Colquhoun K. Glia cells in transected optic nerves of immature rats, 1. An analysis of individual cells by intracellular dye-injection. J Neurocytol 1996; 25: 365-380.
22. McCarthy KD, de Vellis J Alpha-adrenergic receptor modulation of β-adrenergic, adenosine and prostaglandin E1 increased adenosine 3′, 5′-cyclic monophosphate levels in primary cultures of glia. J Cyclic Nucleotide Protein Phosphor Res 1978; 4: 15-16
23. McCarthy KD, de Vellis J. Preparation of separate astroglial and oligodendroglia cell cultures from rat cerebral tissues. J Cell Biol 1980; 85: 890-902.
24. Corbin JG et al. Targeted CNS expression of interfcron-γ in transgenic mice leads to hypomyelination, reactive gliosis, and abnormal cerebella development. Mol Cell Neurosci 1996; 7: 354-370.
25. Snyder RO, Xiao X, Samulski RJ. Production of recombinant adeno-associated virus vectors. In. Dracopoli N et al (eds). Current Protocols in Human Genetics. John Wiley & Sons: New York, 1996, pp 12.1.1-12.2.23.
26. Ausubel FM et al. Current Protocols in Molecular Biology. Greene Publishing Associates, and John Wiley & Sons: New York, 1993, pp 2.0.1-2.13.3.
27. Samulski RJ, Chang LS, Shenk T. Helper-free stocks of recombinant adeno-associated viruses: normal integration does not require viral gene expression. J Virol 1989; 63: 3822-3828.
28. Yakobson B, Koch T, Winocour E. Replication of adeno-associated virus in synchronized cells without the addition of a helper virus. J Virol 1987, 61: 972-981.